Breaking, exciting news! On November 20, 2020, PRF achieved an important piece of our mission: lonafarnib, the first-ever treatment for Progeria, has been granted FDA approval. Progeria now joins less than 5% of the rare diseases with an FDA-approved...
Workshop 2020Agenda Speakers Speaker’s Articles Organizing Committee Over 370 registrants from 30 countries attended our 1st ever web-based Scientific Meeting! We hope you enjoy this clip from our 2020 International Workshop, “Researching Possibilities, ExTENding...
